JP1 peptide may reduce cell damage and support cell cleanup systems through antioxidant pathways in ALS model mice

The study investigates the effects of JP1 on the Keap1–Nrf2–ARE pathway in a mouse model of amyotrophic lateral sclerosis (ALS).

• JP1 is derived from the JWA protein and designed to penetrate the blood-brain barrier.
• Activation of the MEK/ERK–Nrf2 axis is crucial for the neuroprotective effects associated with JWA.
• The Keap1–Nrf2–ARE pathway may play a significant role in regulating oxidative stress and autophagy in ALS.
• The SOD1–G93A mouse model is utilized to assess the potential therapeutic effects of JP1 on ALS.

Simplified